This announcement is a separate document:
天津發展：須予披露及關連交易 - 出售天津力生製藥股份有限公司所持之天津醫藥集團財務有限公司15%股權及股東特別大會通告
TIANJIN DEV: Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary General Meeting
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.